These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37231991)

  • 1. Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.
    Ma Z; Ye W; Wang J; Huang X; Huang J; Li X; Hu C; Li C; Zhou Y; Lin X; Wei W; Qian Y; Zhou Y; Mao S; Yin X; Zhu B; Jin J
    Br J Haematol; 2023 Aug; 202(3):566-577. PubMed ID: 37231991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
    Yang R; Li X; Wu Y; Zhang G; Liu X; Li Y; Bao Y; Yang W; Cui H
    Oncogene; 2020 Apr; 39(14):2975-2986. PubMed ID: 32034306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers.
    Yusuf RZ; Saez B; Sharda A; van Gastel N; Yu VWC; Baryawno N; Scadden EW; Acharya S; Chattophadhyay S; Huang C; Viswanathan V; S'aulis D; Cobert J; Sykes DB; Keibler MA; Das S; Hutchinson JN; Churchill M; Mukherjee S; Lee D; Mercier F; Doench J; Bullinger L; Logan DJ; Schreiber S; Stephanopoulos G; Rizzo WB; Scadden DT
    Blood; 2020 Sep; 136(11):1303-1316. PubMed ID: 32458004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc
    Guo W; Li K; Sun B; Xu D; Tong L; Yin H; Liao Y; Song H; Wang T; Jing B; Hu M; Liu S; Kuang Y; Ling J; Li Q; Wu Y; Wang Q; Yao F; Zhou BP; Lin SH; Deng J
    Cancer Res; 2021 Feb; 81(3):552-566. PubMed ID: 33229341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia.
    Cunningham A; Oudejans LL; Geugien M; Pereira-Martins DA; Wierenga ATJ; Erdem A; Sternadt D; Huls G; Schuringa JJ
    Blood Adv; 2024 Jan; 8(1):56-69. PubMed ID: 37906522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.
    Jin L; Li D; Alesi GN; Fan J; Kang HB; Lu Z; Boggon TJ; Jin P; Yi H; Wright ER; Duong D; Seyfried NT; Egnatchik R; DeBerardinis RJ; Magliocca KR; He C; Arellano ML; Khoury HJ; Shin DM; Khuri FR; Kang S
    Cancer Cell; 2015 Feb; 27(2):257-70. PubMed ID: 25670081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.
    Ye Y; Chen A; Li L; Liang Q; Wang S; Dong Q; Fu M; Lan Z; Li Y; Liu X; Ou JS; Lu L; Yan J
    Kidney Int; 2022 Dec; 102(6):1259-1275. PubMed ID: 36063875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.
    He J; Li F; Zhou Y; Hou X; Liu S; Li X; Zhang Y; Jing X; Yang L
    Cancer Lett; 2020 Jan; 469():419-428. PubMed ID: 31734356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
    Pardieu B; Pasanisi J; Ling F; Dal Bello R; Penneroux J; Su A; Joudinaud R; Chat L; Wu HC; Duchmann M; Sodaro G; Chauvel C; Castelli FA; Vasseur L; Pacchiardi K; Belloucif Y; Laiguillon MC; Meduri E; Vaganay C; Alexe G; Berrou J; Benaksas C; Forget A; Braun T; Gardin C; Raffoux E; Clappier E; Adès L; de Thé H; Fenaille F; Huntly BJ; Stegmaier K; Dombret H; Fenouille N; Lobry C; Puissant A; Itzykson R
    Leukemia; 2022 Jun; 36(6):1585-1595. PubMed ID: 35474100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Gregory MA; Nemkov T; Reisz JA; Zaberezhnyy V; Hansen KC; D'Alessandro A; DeGregori J
    Exp Hematol; 2018 Feb; 58():52-58. PubMed ID: 28947392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of P2X7 Receptor Decreases Basal Glutathione Level by Changing Glutamate-Glutamine Cycle and Neutral Amino Acid Transporters.
    Park H; Kim JE
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.
    Ahmed N; Laverick L; Sammons J; Baumforth KR; Hassan HT
    Leuk Res; 1999 Aug; 23(8):741-9. PubMed ID: 10456672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.
    Hutson SM; Islam MM; Zaganas I
    Neurochem Int; 2011 Sep; 59(4):518-24. PubMed ID: 21621574
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.